Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)
This study is currently recruiting participants.
Verified August 2017 by Yong-Lim Kim, Clinical Research Center for End Stage Renal Disease, Korea
Clinical Research Center for End Stage Renal Disease, Korea
First Posted: July 2, 2009
Last Update Posted: August 22, 2017
Ministry of Health & Welfare, Korea
Kyungpook National University
Daegu Metropolitan City, Korea
National Clinical Research Coordination Center, Seoul, Korea
Medical Research Collaborating Center, Seoul, Korea
Information provided by (Responsible Party):
Yong-Lim Kim, Clinical Research Center for End Stage Renal Disease, Korea
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||September 2018|
|Estimated Primary Completion Date:||September 2018 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Oh HJ, Lee MJ, Lee HS, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW. NT-proBNP: is it a more significant risk factor for mortality than troponin T in incident hemodialysis patients? Medicine (Baltimore). 2014 Dec;93(27):e241. doi: 10.1097/MD.0000000000000241.
Choi JY, Jang HM, Park J, Kim YS, Kang SW, Yang CW, Kim NH, Cho JH, Park SH, Kim CD, Kim YL; Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators. Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea. PLoS One. 2013 Dec 30;8(12):e84257. doi: 10.1371/journal.pone.0084257. eCollection 2013.